🔴 Alvotech is trading 3.41% down today with no confirmed fresh catalyst

Alvotech is trading 3.41% down at ISK 624, versus a close of ISK 646 on September 16, with the decline appearing to be an unexplained pullback.

• Barclays upgraded Alvotech to Overweight and doubled its price target to $8.00 on September 16.
• Alvotech is scheduled to hold investor meetings at Deutsche Bank’s Healthcare Summit on September 17.
• Available September 17 coverage identifies no new negative company-specific announcement.